BioMarin Pharmaceutical Inc. Announces Chief Financial Officer Jeffrey Cooper to Leave the Company

NOVATO, Calif., Feb. 21, 2012 (GLOBE NEWSWIRE) -- BioMarin Pharmaceutical Inc. (Nasdaq:BMRN) announced today that Jeffrey Cooper, Senior Vice President and Chief Financial Officer, plans to leave the company. He will stay in his current role through the middle of the year and then transition to an advisory role until the end of 2012.

MORE ON THIS TOPIC